Core Viewpoint - The stock of Dreamland (01119) has increased by over 9%, reaching HKD 1.26 with a trading volume of HKD 28.46 million, following the announcement of a capital agreement with Playrix's PLR Worldwide Sales Limited [1] Group 1: Investment Agreement - On July 29, Dreamland announced a capital agreement with PLR Worldwide Sales Limited, where the latter will subscribe to approximately 38.08 million shares at HKD 1.024 per share, totaling an investment of HKD 39 million [1] - After the transaction, Playrix will hold approximately 2.11% of Dreamland's shares [1] Group 2: Strategic Implications - Market analysts suggest that the investment from Playrix may facilitate the overseas release of Dreamland's game "Kara Bichu" [1] - PLR Worldwide Sales Limited specializes in mobile game development, multi-platform marketing, distribution, and operation, with key products like "Dream Garden" and "Dream Home," which have significantly contributed to Dreamland's revenue [1] - The board believes that this capital agreement will introduce a long-term cooperative upstream developer as a strategic shareholder, preserve the group's cash flow for future business development, and strengthen the group's financial position [1]

Group 1 - The core point of the article is that Dreamland (01119) has seen a stock price increase of over 9%, currently trading at 1.26 HKD with a transaction volume of 28.46 million HKD [1] - On July 29, Dreamland announced a capital agreement with Playrix's PLR Worldwide Sales Limited, which will subscribe to approximately 38.08 million shares at 1.024 HKD per share, totaling an investment of 39 million HKD [1] - Following the transaction, Playrix will hold approximately 2.11% of Dreamland's shares, indicating a strategic partnership that may facilitate the overseas release of the game "Caribbean" [1] Group 2 - PLR Worldwide Sales Limited specializes in mobile game development, multi-platform marketing, distribution, and operation, with key products like "Garden Dreams" and "Home Dreams," which have significantly contributed to Dreamland's revenue [1] - The board believes that this capital agreement will introduce a long-term cooperative upstream developer as a strategic shareholder, preserve the group's cash flow for future business development, and strengthen the group's financial position [1]

Group 1 - The Hang Seng Index fell by 0.43%, down 109 points, while the Hang Seng Tech Index dropped by 1.57%. The morning trading volume in Hong Kong stocks was HKD 148.2 billion [1] - The Hang Seng Biotechnology Index rose by 1.77%, with notable gains from MicroPort Medical (00853) up 9.7%, MicroPort NeuroScience (02172) up over 8%, and Innovent Biologics (01801) up 4.85% [1] - WuXi AppTec (02359) increased by 2.24%, WuXi Biologics (02126) rose by 6.5%, and WuXi Biologics (02269) saw an increase of over 3% after announcing the construction of a modular biomanufacturing facility in Singapore [1] Group 2 - Mindray Medical-B (02160) surged by 8.8% as the company is expected to acquire and restructure the MicroPort cardiac rhythm management business, enhancing its product pipeline [2] - Insurance stocks continued to rise, with New China Life Insurance (01336) up 4.47% and China Life Insurance (02628) increasing by 1.5% [3] Group 3 - 361 Degrees (01361) rose by 6.5%, with the company showing steady revenue growth, and institutions expect strong revenue growth for the full year [4] - Dreamscape (01119) increased by 3.5% after signing a capitalization agreement with Playrix, bringing in a long-term strategic partner [5] Group 4 - GAC Group-B (01167) surged over 20% as a concerted action party increased its holdings by over 60,000 shares, raising its stake to 25.36% [6] - Semiconductor stocks collectively declined, with Hua Hong Semiconductor (01347) down 5.3%, SMIC (00981) down 3.9%, and ASMPT (00522) down 2.74% [6]

Market Overview - The Hang Seng Index fell by 0.43%, down 109 points, while the Hang Seng Tech Index decreased by 1.57%. The early trading volume in Hong Kong stocks was HKD 148.2 billion [1]. Biotechnology Sector - The Hang Seng Biotechnology Index rose by 1.77%. Notable gainers included MicroPort Medical (00853) up 9.7%, MicroPort NeuroTech (02172) up over 8%, and Innovent Biologics (01801) up 4.85% [1]. - WuXi AppTec (02359) increased by 2.24%, WuXi Biologics (02126) rose by 6.5%, and WuXi Biologics (02269) saw an increase of over 3% following the announcement of the construction of a modular biologics manufacturing facility in Singapore [1]. - Fosun Pharma (02196) gained over 5% after acquiring exclusive rights for the innovative Alzheimer's drug AR1001 [1]. - HeartCare Medical-B (02160) surged by 8.8% as the company is expected to acquire and restructure MicroPort's cardiac management business, enhancing its product pipeline [1]. Insurance Sector - Insurance stocks continued their upward trend, with New China Life Insurance (01336) rising by 4.47% to reach a new high, and China Life Insurance (02628) increasing by 1.5% [2]. Consumer Sector - 361 Degrees (01361) rose by 6.5%, with institutions expecting strong revenue growth for the full year [3]. - Dreamland (01119) increased by 3.5% after signing a capitalization agreement with Playrix, bringing in a strategic shareholder from the upstream development sector [4]. Semiconductor Sector - Gako Technology-B (01167) surged over 20% as a concerted action party increased its stake by over 60,000 shares, raising its total holding to 25.36% [5]. - Semiconductor stocks collectively declined, with Huahong Semiconductor (01347) down 5.3%, SMIC (00981) down 3.9%, and ASMPT (00522) down 2.74%. Nvidia's order for 300,000 H20 chips and Morgan Stanley's comments on the potential impact of the 520 unlock on local industry sentiment contributed to this decline [5].

Group 1 - The core viewpoint of the article highlights that Dreamland (01119) has seen a significant increase in its stock price, rising over 55% within the month and currently trading at 1.2 HKD with a transaction volume of 21.36 million HKD [1] - On July 29, Dreamland announced a capital agreement with Playrix's PLR Worldwide Sales Limited, which will subscribe to approximately 38.08 million shares at a price of 1.024 HKD per share, totaling an investment of 39 million HKD [1] - Following the completion of the transaction, Playrix will hold approximately 2.11% of Dreamland's shares, indicating a strategic partnership with a major player in the mobile gaming industry [1] Group 2 - PLR Worldwide Sales Limited specializes in mobile game development, multi-platform marketing, distribution, and operation, with notable products including "Gardenscapes" and "Homescapes" [1] - The board believes that this capital agreement will introduce a long-term cooperative upstream developer as a strategic shareholder, preserve the group's cash flow for future business development, and strengthen the group's financial position [1]

Group 1 - The core viewpoint of the article highlights the significant stock price increase of Dreamland (01119), which has risen over 55% in the month, with a current price of 1.2 HKD and a trading volume of 21.36 million HKD [1] - On July 29, Dreamland announced a capital agreement with Playrix's PLR Worldwide Sales Limited, which will subscribe to approximately 38.08 million shares at 1.024 HKD per share, totaling an investment of 39 million HKD [1] - Following the transaction, Playrix will hold approximately 2.11% of Dreamland's shares, indicating a strategic partnership with a major player in the mobile gaming industry [1] Group 2 - PLR Worldwide Sales Limited specializes in mobile game development, multi-platform marketing, distribution, and operation, with notable products including "Gardenscapes" and "Homescapes" [1] - The board believes that this capital agreement will introduce a long-term cooperative upstream developer as a strategic shareholder, preserve the group's cash flow for future business development, and strengthen the group's financial position [1]

Group 1 - The core viewpoint of the article highlights the significant stock price increase of Chuangmeng Tiandi (01119), which has risen over 55% in the month, with a current price of 1.2 HKD and a trading volume of 21.36 million HKD [1] - On July 29, Chuangmeng Tiandi announced a capital agreement with Playrix's PLR Worldwide Sales Limited, which will subscribe to approximately 38.08 million shares at a price of 1.024 HKD per share, totaling an investment of 39 million HKD [1] - Following the completion of the transaction, Playrix will hold approximately 2.11% of Chuangmeng Tiandi's shares, indicating a strategic partnership with a major player in the mobile gaming industry [1] Group 2 - PLR Worldwide Sales Limited specializes in mobile game development, multi-platform marketing, distribution, and operation, with notable products including "Gardenscapes" and "Homescapes" [1] - The board of Chuangmeng Tiandi believes that this capital agreement will introduce a long-term cooperative upstream developer as a strategic shareholder, preserve the group's cash flow for future business development, and strengthen the group's financial position [1]

Group 1 - The core point of the news is that Dream Games (创梦天地) has signed a capital agreement with Playrix's PLR Worldwide Sales Limited, where Playrix will subscribe to approximately 38.08 million shares at HKD 1.024 per share, totaling HKD 39 million, which represents a discount of about 3.4% from the closing price on July 28 [1] - Following this transaction, Playrix will hold approximately 2.11% of Dream Games' shares, indicating a strategic investment based on the company's strengths in the overseas premium game distribution business [1] - Dream Games has successfully launched the "Dream Series" games in China, achieving over 200 million registered users over eight years, with "Dream Garden" reaching record revenue in 2024 [1] Group 2 - Game industry research media GameLook analyzed how Dream Games has become a unique global distribution platform by deeply understanding game content and accurately connecting with culture, successfully introducing and operating several well-known IPs [2] - Dream Games has announced a profit forecast for the first half of 2025, expecting net profits between RMB 20 million and 50 million, driven by the results of strategic adjustments and the gradual delivery of self-developed products [2] - The company is set to enter a product launch phase in the second half of 2025, with multiple games, including "Kara Bichu" and "Chong Chong Qibing," expected to be released, showcasing the recognition from overseas developers of Dream Games' capabilities in premium game distribution [2][3] Group 3 - Dream Games is focusing on introducing unique vertical niche products and has reserved several overseas premium games, indicating a shift in collaboration with overseas developers from "agency distribution" to "equity binding," which is expected to create a stable and mutually beneficial long-term partnership [3] - The upcoming product launches and the strategic investment from Playrix are anticipated to accelerate the company's performance release period [3]

Group 1 - The company, Dreamland (01119), announced a capitalization agreement with a subscriber, agreeing to issue 38.0859 million subscription shares at a price of HKD 1.024 per share, which will offset the franchise fees owed to the subscriber [1] - The subscription shares represent approximately 2.11% of the company's expanded issued share capital post-capitalization, assuming no other changes in the issued share capital [1] - The subscription price of HKD 1.024 per share reflects a discount of about 3.40% compared to the closing price of HKD 1.06 on the Hong Kong Stock Exchange on July 28, 2025 [1] Group 2 - The subscriber, PLR Worldwide Sales Limited, is an Irish limited liability company primarily engaged in mobile game development, multi-platform marketing, distribution, and operation, with major products including "Dream Garden" and "Dream Home" [2] - PLR Worldwide Sales Limited is wholly owned by Playrix Holdings Limited, with Dmitrii Bukhman and Igor Bukhman each holding 48.8% of Playrix Holdings Limited [2] - The board believes that the capitalization will (i) introduce a long-term cooperative upstream developer as a strategic shareholder, (ii) preserve the group's cash flow for future business development, and (iii) strengthen the group's financial position [2]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或 因倚賴該等內容而引致之任何損失承擔任何責任。 認購股份將根據於2024年股東週年大會上批准之一般授權發行，因此毋須 取得股東進一步批准。本公司將向香港聯交所上市委員會申請批准認購股 份上市及買賣。 資本化協議及其項下擬進行之交易須待當中所載先決條件獲達成後方告完成。 有關進一步資料，請參閱下文「資本化協議」一段。由於資本化事項可能會 或可能不會完成，股東及潛在投資者於買賣本公司證券時務請審慎行事。 – 1 – 根據一般授權發行新股份 iDreamSky Technology Holdings Limited ࡋỖཙൠ、ᢰ᧗㛑ᴹ䲀ޜਨ （於開曼群島註冊成立的有限公司） （股份代號：1119） 根據一般授權發行新股份 董事會宣佈，於2025年7月28日（交易時段後），本公司及深圳創夢與認購人 訂立資本化協議，據此，認購人已有條件同意認購，而本公司已有條件同 意按每股認購股份1.024港元的發行價向認購人配發及發行38,085,937股認購 股份，以按等 ...